| Term 
 
        | MOA: Balanced Vasodilation -Decreases LVH > Prolongs Life -Increases renal blood flow > Diuresis > decr. pulmonary congestion > incr. quality of life   DOC- HF, LVH, DM, post MI systolic dysfunction   Toxicity- CART HH Cough  Angioedema  Renal Insufficiency  Teratogen  Hypotension with first dose  HypERkalemia   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Use the smallest dose to prevent hypotension treats systolic dysfunction |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | A 3 of these drugs: treat heart failure decrease pulmonary congestion by decreasing preload diuretics |  | Definition 
 
        | Furosemide Spironolactone Epleronone |  | 
        |  | 
        
        | Term 
 
        | causes hypERkalemia take with captopril since it has short half life |  | Definition 
 
        | Spironolactone Epleronone |  | 
        |  | 
        
        | Term 
 
        | All 3 of these diuretics reverse cardiac remodeling which prolongs life |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | GFR must be >30 to work treats hypertension causes decr. insulin sensitivity causes muscle weakness |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Both of these drugs: cause hypOkalemia -which worsens Digoxin AEs To prevent hypOkalemia give with: ARBs, ACE inhibitors, spironolactone, B blockers, amiloride or resistrict salt and take potassium supplements |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: decrease SNS by blocking a1, b1, b2 receptors decreases contractility > reverses LVH > prolongs life Balanced Vasodilation > decr. afterload & incr. SV > incr. EF -- can use in pt's with EF < 35%   decr. HR > incr. filling time> shunts blood to endocardium   salt/water retention > leads to pseudotolerance   decreases automaticity > incr. ERP (most in AV only, sotalol in vent. and atrium also) --> slow conduction |  | Definition 
 
        | B blockers   propranolol atenolol esmol sotalol |  | 
        |  | 
        
        | Term 
 
        | blocks K+ channels> incr. ERP & APD in atria, ventricle, AV node --> TORSADES   DOC for recurrent V. tach   also use to cardiovert people with A. fib |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | treats heart failure "Start low, go slow" EF falls initially but then increases  |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | DOC for hypertensive emergency |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | use IV Dysrrhythmia during cardiac catheterization |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Treat PVCs and tremors from stress |  | Definition 
 
        | Propranolol Other B blockers will work also |  | 
        |  | 
        
        | Term 
 
        | Treats chronic AVNRT, angina, heart failure, hypertension, v tach |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: decr. contractility & decr. HR > blocks slow fibers in AV node> incr. ERP in AV node   also decr. SBP, SV, CO, wall tension   incr arterial compliance and blood flow to heart   Treats: Angina, chronic AVNRT   Toxicity- AV block |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Causes constipation & AV block   Do NOT give with B blocker or Digoxin     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Causes AV block   Do NOT give with cimetidine or digoxin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: dilate arterioles > decr. afterload = decr. DBP > decr. wall tension and incr. BF to heart and incr. large artery compliance   Treats angina and hypertension   Toxicity- Pedal edema, paradoxical angina   do NOT give with grapefruit juice |  | Definition 
 
        | DHP's Amlodipine Nefedipine Fenlodipine |  | 
        |  | 
        
        | Term 
 
        | A patient comes in with heart failure and A. fib. You want to keep their ventricular rate down. What do you give them? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | A patient comes in with worsened heart failure. They're on furosemide, lisinopril, dinitrate, hydralazine, spironolactone, carvedilol. What drug should you try next? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Apatient comes in with sudden chest pain and a ventricular rate of 200 and you think it might be AVNRT. You give them a drug and the dysrrhythmia goes away-- what drug did you give them?   What drugs should you send them home with? |  | Definition 
 
        | Adenosine   Send home with B blocker or verapamil |  | 
        |  | 
        
        | Term 
 
        | use this drug to diagnose or cardiovert someone with AVNRT to normal rhythm |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | decr. phase 4 automaticity in fast fibers causes 2 way block to prevent reentry dysrrhythmia prevents automaticity in ischemic tissue   Treats V. tach, digoxin induced PVCs   Toxicity- seizures |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA- blocks Nain and Kout, noncompetitive a and b blocker, incr. ERP & ADP in atrium, ventricle, AV node   Prolongs PR, QRS, QT   use- cardiovert A. fib, turn Vtach to sinus rhythm, prophylaxis for Vtach   Class III- K channel blocker   toxicity- FATAL pulmonary fibrosis, purple man, thyroid problems |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | decr. preload and afterload and mortality especially in blacks     |  | Definition 
 
        | Isosorbide dinitrate + hydralazine (arterial dilator)     |  | 
        |  | 
        
        | Term 
 
        | causes SLE-like symptoms treat heart failure in blacks |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: NO donor which decreases preload and wall tension selective venodilation, decr. oxygen demand slight incr. in myocardial blood flow to reverse ischemia   NO effect on afterload |  | Definition 
 
        | Nitrates: Nitroglycerin Dinitrate Mononitrate |  | 
        |  | 
        
        | Term 
 
        | Causes headaches and orthostatic hypertension   PO form has a potential for tolerance   SL acutely causes incr HR, incr. contractility, decr DBP sit down while dosing |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA- blocks GI transporter so cholesterol can't be absorbed   does NOT need LDL receptors to lower LDL   2nd choice anti-lipemic drug   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: stimulates GPR109A receptor -decr. TG via lipolysis -decr. LDL due to decr. VLDL & making bigger LDL particles -decr. VLDL via ApoB100 degradation -incr. HDL by preventing the liver from destroying HDL-ApoA> incr. direct pathway to reverse chol. transport   used to treat people with mixed hyperlipidemias (incr. LDL & TG)   Toxicities- flushing and pruritis at start. aspirin laropiprant helps by blocking PGD2   DON'T give with statin- worsens myopathy |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: ion exchange resins. causes bile acids to be lost in feces> more chol is used to make bile thus decr. pool   Effect- decr. LDL ONLY   Toxicities- constipation decreases bioavailability of warfarin & pravastatin |  | Definition 
 
        | Bile Acid Binders: Cholestyramine Colestipol Colesevelam |  | 
        |  | 
        
        | Term 
 
        | used to lower LDL in pt w/ CV risk does not affect bioavailability of other drugs safe in preg. women take 6 pills/day |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: binds to PPARa   -decr. TG by stimulating PPARa > incr. VLDL clearance & decr. VLDL synthesis -decr. VLDL by reducing ApoCIII expression and incr. lipase synthesis
 -decr. LDL by incr. SREBP synth > incr. LDL rec's -incr. HDL by incr. ApoA1 synth.   Use in diabetics- esp. for VLDL and HDL   |  | Definition 
 
        | Fibrates: Fenofibrate Gemfibrozil |  | 
        |  | 
        
        | Term 
 
        | MOA: HMG CoA reductase inhibitor > can't make cholesterol > incr. LD rec's   Increases cholesterol plaque stability   Toxicities- myositis, teratogen, fatal rhabdomyolysis |  | Definition 
 
        | Statins: Simvastatin Pravastatin Atorvastatin Rosuvastatin |  | 
        |  | 
        
        | Term 
 
        | Which 2 statins are NOT metabolized by cytochrome P450? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: cleaves plasminogen to form plasmin   degrades everything in site, including factors 5, 8, fibrinogen   use- MI, PE, DVT, stroke   Antidote- Aminocaproic Acid   |  | Definition 
 
        | Fibrinolytics: TPA Alteplase Streptokinase |  | 
        |  | 
        
        | Term 
 
        | MOA: prevents vitamin K from being reduced > factors 2, 5, 7, 9, 10 can't get made   Treat- DVT, prevent thromboembolism in A. fib and prosthetic valves   Toxicities- teratogenic, metab. by P450 Antibiotics increase its activity due to destroying gut flora   increases INR   Antidote- phytonadione |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA1- anti-platelets- makes wall neg. so platelets can't bind> incr. bleeding time   MOA2- anti-coagulant- binds to ATIII to inhibit clotting factors 2, 9-12   Use: DVT prophylaxis, treat DVT & PE, history of thrombosis, during pregnancy   half life increases as dose is increased use PTT to measure activity   Antidote- protamine sulfate |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What causes heparin resistance? |  | Definition 
 
        | 1. PE increases heparin clearance 2. Congenital ATIII deficiency 3. Acquired ATIII deficiency- cirrhosis, nephrotic syndrome, DIC 4. Acute phase proteins |  | 
        |  | 
        
        | Term 
 
        | MOA: binds ATIII to inhibit factor 10   Use: DVT prophylaxis, stroke, ACS, dialysis         |  | Definition 
 
        | LMW heparins: Ardeparin Dalteparin Enoxaparin |  | 
        |  | 
        
        | Term 
 
        | MOA- binds to ATIII to inhibit factors 2, 9-12   Use: DVT, PE, HIT |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Direct inhibitor of factor 10 Use- DVT   Toxicity- BLEEDING   Metabolized by P450   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA- direct, irreversible inhibitor of 2a   Use- HIT     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | take IV   MOA- Direct, reversible inhibitor of 2   Use- HIT, DVT   Increases INR when given with warfarin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA- direct reversible inhibitor of 2   Use- prevents thrombosis in A. fib   Toxicity- gastritis & dyspepsia |  | Definition 
 
        | Dabigatran   Eating da big mac can give you dyspepsia   |  | 
        |  | 
        
        | Term 
 
        | irreversible COX1 inhibitor   prevents TXA2 production   increases bleeding time |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA- blocks II/III receptor so nothing can bind to platelet including fibrinogen   Use- PCI, ACS- MI or unstable angina   incr. bleeding time |  | Definition 
 
        | TEA Tirofiban Eptifibatide Abciximib |  | 
        |  | 
        
        | Term 
 
        | Monoclonal antibody- irreversibly blocks II/III receptor so nothing can bind to platelets |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Competitive inhibitors of II/III receptor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA- blocks the P2Y(12) receptor that ADP binds to> platelets can't aggregate   Use- with aspirin to prevent MI or stroke -if you have an aspirin hypersensitivity -secondary prevention of stroke   incr. bleeding time |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-platelet med   causes neutropenia   give 10 days to get full effect |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Irreversible inhibitor of P2Y(12) receptor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Same MOA as ACE inhibitors Balanced Vasodilators Angiotensin II receptor blockers Increases compliance of small and larger arteries   Use- hypertension and heart failure   Toxicity- teratogenic, angioedema, hyperkalemia, hypotension   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What do you treat hypertensive kids and pregnant women with?   Toxicity- sedation, dry mouth, rebound hypertension |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | a2 adrenocceptor agonist in brain> reduces sympathetic outflow balanced vasodilation incr. FF > salt/water retention> pseudotolerance decreases rening and angII   Use- Hypertension   Toxicity- vivid dreams, orthostatic intolerance withdrawal syndrome- incr. BP, tremor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA: NO dilates arteries and inhibits platelet aggregation Balanced vasodilator   Use: hypertensive emergencies in SUPINE patients stops dissecting aortic aneurysm   Super short half-life (30s) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Only use if other drugs haven't been able to decrease their hypertension   MOA: vasodilates resistance arterioles> incr. HR, incr CO> take with B blocker causes salt/water retention |  | Definition 
 
        | Hydralazine Minoxidil Diazoxide |  | 
        |  | 
        
        | Term 
 
        | causes hairiness= hypertrichosis   also causes edema, angina |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   MOA:   Antidote:   Aspirin |  | Definition 
 
        | incr. BT TXA2 via irreversible COX1 inhibitor none |  | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed: MOA: Antidote:   abciximab eptifibatide tirofiban |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   MOA:   Antidote:   clopidogrel ticlopidine   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed: Clotting factors: MOA: Antidote:   Heparin   |  | Definition 
 
        | incr. BT, incr. PTT 2, 9-12 ATIII Protamine sulfate   |  | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed: Clotting factors: MOA: Antidote:   Ardeparin Dalteparin Enoxaparin |  | Definition 
 
        | no changes 10 ATIII Protamine sulfate- partial |  | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote:   Fondaparinux sc   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote:   Rivaroxaban   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote:     Lepirudin IV |  | Definition 
 
        | incr. PTT 2a Direct and IRREVERSIBLE None |  | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote:   Argatroban   |  | Definition 
 
        | incr. PTT 2 Direct none   may incr. INR when given with warfarin |  | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote:   Dabigatran   |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote:   warfarin po- normal dose   |  | Definition 
 
        | incr. INR (PT) 2, 7, 9, 10 Decr. Vit KH2 Phytonadione |  | 
        |  | 
        
        | Term 
 
        | Which hemodynamic values get changed:   Clotting factors:   MOA:   Antidote: Side effects:   warfarin po- overdose |  | Definition 
 
        | incr PTT and INR (PT) 2, 7, 9, 10 decr. vitKH2 phytonadione causes PACs, PVCs, AV block, affects green-yellow vision |  | 
        |  | 
        
        | Term 
 
        | Name the 4 groups of drugs that increase bleeding time: |  | Definition 
 
        | Anti-platelets: Aspirin II/III inhibitors- tiro, epti, abc P2y(12) inhibitors- ticlopidine, clopidogrel Heparin |  | 
        |  | 
        
        | Term 
 
        | Name the 4 drugs that can increase PTT |  | Definition 
 
        | Factor 2 inhibitors:   LAD + warfarin overdose Lepirudin Argatroban Dabigatran |  | 
        |  | 
        
        | Term 
 
        | Name the drug that increases PT (INR) |  | Definition 
 
        | Warfarin   --increased further by argatroban |  | 
        |  | 
        
        | Term 
 
        | Name the 7 drugs that inhibit factor 10 |  | Definition 
 
        | FADE With Hot Rain   Fondaparinux Ardeparin Dalteparin Enoxaparin   Warfarin Heparin Rivaroxaban   |  | 
        |  | 
        
        | Term 
 
        | Name the 4 drugs that only inhibit factor 10 thru ATIII |  | Definition 
 
        | FADE Fondaparinux + LMW heparins Ardeparin Dalteparin Enoxaparin |  | 
        |  | 
        
        | Term 
 
        | Slow: Which drugs decrease conduction throught the AV node?   Fast: Which drugs decrease ventricular conduction?   Which decrease automaticity in both? |  | Definition 
 
        | 1. Verapamil, Digoxin, Adenosine   2. Lidocaine    3. B blockers incl. Sotalol, Amiodarone |  | 
        |  | 
        
        | Term 
 
        | Which drugs cause salt and water retention? |  | Definition 
 
        | B blockers Clonidine Hydralazine, Minoxidil, Diazoxide |  | 
        |  | 
        
        | Term 
 
        | Name 4 causes of resistance to warfarin: |  | Definition 
 
        | 1. Cytochrome P450 2. Hypoalbuminemia- nephrotic syndrome 3. Anion exchange resins like cholestyramine, colestipol 4. Increased K intake |  | 
        |  | 
        
        | Term 
 
        | Which drug causes Torsades? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | B blockers Digoxin Verapamil, Dilt |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SL NTG Hydralazine, Minoxidil, Diazoxide |  | 
        |  | 
        
        | Term 
 
        | 1. Drugs that cause hypOkalemia   2. Drugs that cause hypERkalemia |  | Definition 
 
        | 1. HCTZ, Furosemide 2. Spiro/Epleronone, ACEinhibitors/ARBs |  | 
        |  | 
        
        | Term 
 
        | How do you treat people with cyanide toxicity due to sodium nitroprusside? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What makes digoxin toxicity worse? |  | Definition 
 
        | low K, hyperaldosteronism low Mg, HIGH Ca Slow conductors: B blockers, Verapamil Spironolactone- decreases renal clearance     |  | 
        |  | 
        
        | Term 
 
        | What is the DOC for acute V fib? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the DOC for chronic V fib |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How do statins lower LDL? |  | Definition 
 
        | By competitively inhibiting HMG CoA reductase |  | 
        |  | 
        
        | Term 
 
        | What is the MOA of lidocaine? |  | Definition 
 
        | "stuns" the heart so it can't react to other drugs (ie digoxin) 1. suppresses ventricular automaticity > decreases spontaneous phase 4 depolarization in ischemic/digoxin tissue > decr. PVCs in ischemic tissue 2. causes 2 way block to stop reentry v. tach 3. increases threshold potential to further suppress automaticity   --no effect on AV conduction and no effect on EKG |  | 
        |  | 
        
        | Term 
 
        | Which drug is associated with sedation? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which drugs block AV node only? |  | Definition 
 
        | Verapamil- directly Digoxin- via vagal stimulation Adenosine |  | 
        |  | 
        
        | Term 
 
        | Which drugs prevent PVCs? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which drugs block AV node, atrium, ventricle? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which drugs cause salt/water retention? |  | Definition 
 
        | B blockers Clonidine Hydralazine, Minoxidil, Diazoxide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B blockers Verapamil Digoxin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SL Nitro- acutely Hydralazine, Minoxidil, Diazoxide   Slight- Sodium Nitroprusside, Nifedipine, Amlodipine, Felodipine |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Spiro/Epleronone ACE inhibitors/ARBs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | I'll pay CASH just for some balanced vasodilation Clonidine ACE inhibitors/ARBs Sodium Nitroprusside Hydralazine + Dinitrate   |  | 
        |  | 
        
        | Term 
 
        | Increase Arterial Compliance |  | Definition 
 
        | ACEinhibitors/ARBs Dihydropyridines |  | 
        |  |